Faculty Profiles

Colleges and Departments

Dr. Liqin Du

  • Associate Professor at Chemistry and Biochemistry, College of Science & Engineering

Grants

2025

  • Du, Liqin (Principal). Targeting the human druggable genome for neuroblastoma differentiation therapy, Texas State University, REP Program, Texas State University, $8000. (Submitted: October 9, 2024, Funded: January 27, 2025 - May 31, 2026). Grant.

2024

  • Du, Liqin (Principal). Developing new research directions in my laboratory, Texas State University, Presidential Research Award, Texas State University, $20000. (Submitted: September 15, 2023, Funded: July 2, 2024 - May 31, 2025). Grant.
  • Peterson, Ryan Loren, Lewis, Lysle, Du, Liqin, McLean, Robert J C. Fluorescence Microscope with Live-cell and high-resolution imaging capabilities, NIH, Federal, $194590.3. (Funded: July 1, 2024 - June 30, 2025). Grant.

2020

  • Du, Liqin (Principal). Molecular and therapeutic mechanisms of differentiation-inducing microRNA miR-506-3p in neuroblastoma, National Institute of Health, NCI, R15, Federal, $445639. (Submitted: June 6, 2019, Funded: September 1, 2020 - August 31, 2024). Grant.
  • Du, Liqin (Principal). Developing novel miR-506-3p analogs that induce neuroblastoma cell differentiation, Texas State University, REP Program, Texas State University, $8000. (Submitted: October 8, 2019, Funded: January 15, 2020 - December 31, 2021). Grant.

2017

  • Du, Liqin (Principal), Percent Contribution: %10, Kornienko, Alexander (Other), Percent Contribution: %5, Houhgton, Peter (Other), Percent Contribution: %1. Discovery of new differentiation agents for neuroblastoma therapy, National Institute of Health, NCI, R15, resubmissiom, Federal, $461574. (Funded: August 1, 2017 - July 31, 2020). Grant.
  • Du, Liqin (Principal). Determining the therapeutic potential of rooperol in neuroblastoma, Texas State University, REP Program, Texas State University, $8000. (Funded: January 1, 2017 - May 31, 2018). Grant.

2016

  • Kerwin, S (Principal), Du, Liqin (Co-Principal). Hypoxis-derived treatment for advanced lung cancer, William and Ella Owens Medical Research Foundation, Research grant, Private / Foundation / Corporate, $153109. (Funded: January 1, 2016 - December 31, 2017). Grant.

2015

  • Du, Liqin (Principal). Identifying a novel oncogenic mechanism and diagnostic marker for neuroendocrine lung cancer, Peter Bradley Carlson Trust, Research Pilot Award, $30000. (Funded: January 1, 2015 - December 31, 2015). Grant.

2014

  • Pertsemlidis, A (Principal), Du, Liqin (Co-Principal). Elucidating how chromosome 21 protects against neuroblastoma occurrence, Institute for Integration of Medicine and Science, UT Health SA, Pilot Project Award, Institutional (Higher Ed), $50000. (Funded: October 4, 2014 - September 30, 2015). Grant.
  • Du, Liqin (Other), Cichewicz, Robert, Mooberry, Susan. Identify bioactive natural products from the Great Lakes fungi for treating pediatric cancers, National Institute of Health, NIGMS, Multi-PI R01, Federal, $861335. (Funded: July 1, 2014 - June 30, 2015). Grant.
  • Pertsemlidis, A . (Principal), Du, Liqin (Co-Principal). What drives the regression in neuroblastoma? Clues from Chromosome 21, Helen Freeborn Kerr Foundation Award, Pilot Award, Private / Foundation / Corporate, $4000. (Funded: July 1, 2014 - June 30, 2015). Grant.

2013

  • Du, Liqin (Principal). Identifying long non-coding RNAs controlling neuroblastoma cell differentiation, Institute for Integration of Medicine and Science, UT Health SA, Pilot Project Award, Institutional (Higher Ed), $50000. (Funded: December 1, 2013 - November 30, 2014). Grant.
  • Du, Liqin (Principal). Identifying microRNAs that induce neuroblastoma cell differentiation, Department of Defense, PRMRP, Discovery Award, Federal, $186828. (Funded: September 1, 2013 - February 28, 2017). Grant.
  • Du, Liqin (Principal). Identifying microRNAs that regulate LMO1 expression in neuroblastoma, Greehey Children’s Cancer Research Institute, Pilot Award, Institutional (Higher Ed), $8100. (Funded: August 1, 2013 - July 31, 2015). Grant.
  • Du, Liqin (Principal). Discovery of new drugs for neuroblastoma from Texas plants, Bank of America Shelby Rae Tengg Foundation, Pilot Award, Private / Foundation / Corporate, $5000. (Funded: July 1, 2013 - June 30, 2014). Grant.

2012

  • Du, Liqin (Principal). Pilot investigation of the role of microRNAs in regulating neuroblastoma cell differentiation, Greehey Children’s Cancer Research Institute, Pilot Award, Other, $10000. (Funded: September 1, 2012 - August 31, 2013). Grant.